Yahoo Web Search

Search results

  1. Nov 13, 2020 · A vaccine candidate developed by the company they co-founded 12 years ago, BioNTech, was more than 90 per cent effective in preventing the disease — a far higher level than the widely-used jabs...

  2. Apr 9, 2020 · BioNTech and Pfizer will work together to scale-up manufacturing capacity at risk to provide worldwide supply in response to the pandemic. BioNTech and Pfizer will also work jointly to commercialize the vaccine worldwide (excluding China, which is already covered by BioNTechs collaboration with Fosun Pharma) upon regulatory approval.

  3. Aug 18, 2022 · 18 August 2022. العربية. 中文. Français. Русский. Español. Português. Updated 18 August 2022, to reflect the latest SAGE recommendations. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for the use of the Pfizer BioNTech (BNT162b2) vaccine against COVID-19.

  4. www.biontech.com › de › deBioNTech

    Unser Glaube an wissenschaftliche Präzision, Innovation und Leidenschaft treibt uns dabei an. BioNTech wurde von Wissenschaftlern und Wissenschaftlerinnen, Ärzten und Ärztinnen gegründet, um durch die Kombination von Wissenschaft und deren optimaler Umsetzung das Leben von Menschen nachhaltig zu verbessern. Lesen Sie mehr.

  5. Sep 11, 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19. The Pfizer-BioNTech...

  6. www.linkedin.com › company › biontech-seBioNTech SE | LinkedIn

    Mainz, Rhineland-Palatinate 235,824 followers. Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. View all 4,419 employees....

  7. Jul 19, 2021 · MAINZ, Germany & SANTA MONICA, Calif.-- (BUSINESS WIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies have entered into a purchase agreement for BioNTech to acquire Kite’s solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility in...

  1. People also search for